Nacuity Pharmaceuticals, Inc. — Form D

Nacuity Pharmaceuticals, Inc. of FORT WORTH, TX, a company, filed a Form D exempt-offering notice with the SEC on 2017-06-27. The offering totals $10.0M, of which $7.3M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Michael WallExecutive OfficerFort Worth, TX
Robin SteeleDirectorFort Worth, TX
David WohlbergDirectorFort Worth, TX
David WohlbergExecutive OfficerFort Worth, TX
Rusty KelleyDirectorFort Worth, TX
Gerald CagleDirectorFort Worth, TX
Jami KernExecutive OfficerFort Worth, TX
Benjamin YerxaDirectorFort Worth, TX
Emmett Cunningham, Jr.DirectorFort Worth, TX
Halden ConnerDirectorFort Worth, TX
Halden ConnerExecutive OfficerFort Worth, TX
Charles LieserExecutive OfficerFort Worth, TX
Robert RuffoloDirectorBoston, MA
Robin SteelDirectorFort Worth, TX
Isaac Michael BlechDirectorNew York, NY
Charles Michael LieserExecutive OfficerFort Worth, TX
G. Michael Wall, Ph.D.Executive OfficerFort Worth, TX
Dr. Gerald D CagleDirectorFort Worth, TX
David J WohlbergDirectorLos Angeles, CA
William Halden ConnerDirectorFort Worth, TX
William Halden ConnerExecutive OfficerFort Worth, TX
Richard Michael Chin, M.D.DirectorSan Francisco, CA
Sanford J HillsbergDirectorLos Angeles, CA

Other filings by this issuer (5)

FiledFormOfferingSold
2025-12-30D$30.0M$8.4M
2022-01-03D/A$17.4M$11.6M
2021-03-30D$11.0M$3.2M
2017-07-20D/A$10.0M$9.2M
2016-12-08D$2.5M$2.0M

More